LLY

767.59

-2.16%↓

JNJ

149.75

-0.73%↓

NVO

74.15

+0.08%↑

ABBV

184.93

-0.24%↓

UNH

303.61

-1.13%↓

LLY

767.59

-2.16%↓

JNJ

149.75

-0.73%↓

NVO

74.15

+0.08%↑

ABBV

184.93

-0.24%↓

UNH

303.61

-1.13%↓

LLY

767.59

-2.16%↓

JNJ

149.75

-0.73%↓

NVO

74.15

+0.08%↑

ABBV

184.93

-0.24%↓

UNH

303.61

-1.13%↓

LLY

767.59

-2.16%↓

JNJ

149.75

-0.73%↓

NVO

74.15

+0.08%↑

ABBV

184.93

-0.24%↓

UNH

303.61

-1.13%↓

LLY

767.59

-2.16%↓

JNJ

149.75

-0.73%↓

NVO

74.15

+0.08%↑

ABBV

184.93

-0.24%↓

UNH

303.61

-1.13%↓

Search

Baxter International Inc

Atvērts

SektorsVeselības aprūpe

30.03 0.7

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

29.65

Max

30.18

Galvenie mērījumi

By Trading Economics

Ienākumi

552M

64M

Pārdošana

-128M

2.6B

P/E

Sektora vidējais

124.8

50.857

EPS

0.55

Dividenžu ienesīgums

2.22

Peļņas marža

2.438

Darbinieki

38,000

EBITDA

501M

325M

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

+18.19% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

2.22%

2.35%

Nākamie ieņēmumi

2025. g. 5. aug.

Nākamais dividenžu datums

2025. g. 1. jūl.

Nākamais Ex dividenžu datums

2025. g. 29. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

103M

16B

Iepriekšējā atvēršanas cena

29.33

Iepriekšējā slēgšanas cena

30.03

Ziņu noskaņojums

By Acuity

49%

51%

148 / 381 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Weak Bullish Evidence

Baxter International Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 19. jūn. 15:04 UTC

Iegādes, apvienošanās, pārņemšana

UniCredit's Banco BPM Bid Gets Conditional EU Nod -- Update

2025. g. 19. jūn. 14:33 UTC

Iegādes, apvienošanās, pārņemšana

UniCredit's Banco BPM Bid Gets Conditional EU Nod

2025. g. 19. jūn. 23:42 UTC

Tirgus saruna

Nikkei May Trade Rangebound Amid Uncertainty Over Israel-Iran Conflict -- Market Talk

2025. g. 19. jūn. 20:50 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2025. g. 19. jūn. 20:50 UTC

Tirgus saruna
Peļņas

Auto & Transport Roundup: Market Talk

2025. g. 19. jūn. 20:38 UTC

Iegādes, apvienošanās, pārņemšana

Home Depot Bid Kicks Off a Battle for $5 Billion Building-Products Company -- WSJ

2025. g. 19. jūn. 20:38 UTC

Iegādes, apvienošanās, pārņemšana

Home Depot Privately Made Bid for Building-Products Distributor GMS, Sources Say -- WSJ

2025. g. 19. jūn. 20:38 UTC

Iegādes, apvienošanās, pārņemšana

Competing Offers Could Prompt Bidding War for GMS, Sources Say -- WSJ

2025. g. 19. jūn. 20:38 UTC

Iegādes, apvienošanās, pārņemšana

Offer From Home Depot Comes as QXO Makes Unsolicited Proposal at $95.20 Per Share -- WSJ

2025. g. 19. jūn. 17:02 UTC

Iegādes, apvienošanās, pārņemšana

Worthington Buys Elgen Manufacturing for About $93M, Funded With Cash on Hand

2025. g. 19. jūn. 17:01 UTC

Iegādes, apvienošanās, pārņemšana

Worthington Enterprises Says Elgen Will Become Part of Its Building Products Segment

2025. g. 19. jūn. 17:01 UTC

Iegādes, apvienošanās, pārņemšana

Worthington Enterprises Acquires Elgen Manufacturing >WOR

2025. g. 19. jūn. 16:20 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2025. g. 19. jūn. 16:20 UTC

Tirgus saruna
Peļņas

Auto & Transport Roundup: Market Talk

2025. g. 19. jūn. 15:37 UTC

Tirgus saruna

European Gas Soars on Middle East Escalation Fears -- Market Talk

2025. g. 19. jūn. 15:16 UTC

Tirgus saruna

Copper Prices Look Set to Fall Over Third Quarter, Citi Says -- Market Talk

2025. g. 19. jūn. 15:16 UTC

Tirgus saruna

Market Talk Roundup: Latest on U.S. Politics

2025. g. 19. jūn. 15:10 UTC

Tirgus saruna

Dollar Rises as Israel-Iran Conflict Intensifies -- Market Talk

2025. g. 19. jūn. 15:10 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 19. jūn. 15:02 UTC

Tirgus saruna

Oil Climbs 2% as Israel-Iran Tensions Mount, With U.S. Role in Focus -- Market Talk

2025. g. 19. jūn. 14:15 UTC

Iegādes, apvienošanās, pārņemšana

EU: UniCredit Committed to Divest 209 Physical Branches in Overlap Areas Across Italy

2025. g. 19. jūn. 14:15 UTC

Iegādes, apvienošanās, pārņemšana

EU: UniCredit Commitments Fully Address Competition Concerns Identified

2025. g. 19. jūn. 14:15 UTC

Iegādes, apvienošanās, pārņemšana

EU Rejected Request From Italian Competition Authority to Refer Deal for National Review

2025. g. 19. jūn. 14:15 UTC

Iegādes, apvienošanās, pārņemšana

EU Approves UniCredit's Acquisition of Banco BPM, Subject to Conditions

2025. g. 19. jūn. 14:15 UTC

Iegādes, apvienošanās, pārņemšana

EU Says There Are No Compelling Reasons to Justify Referral to Italy

2025. g. 19. jūn. 13:58 UTC

Tirgus saruna

Market Talk Roundup: BOE Holds Rates as Focus Turns to Likely August Cut

2025. g. 19. jūn. 13:58 UTC

Tirgus saruna

Market Talk Roundup: BOE Holds Rates as Focus -2-

2025. g. 19. jūn. 13:38 UTC

Tirgus saruna

Canadian Small Firms Appear to Be Coping With Tariffs -- Market Talk

2025. g. 19. jūn. 13:33 UTC

Tirgus saruna

BOE Likely to Cut Rates If Firms' Pricing Power Weakens -- Market Talk

2025. g. 19. jūn. 13:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

Baxter International Inc Prognoze

Cenas mērķis

By TipRanks

18.19% augšup

Prognoze 12 mēnešiem

Vidējais 35.22 USD  18.19%

Augstākais 40 USD

Zemākais 28 USD

Pamatojoties uz 10 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Baxter International Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

10 ratings

3

Pirkt

6

Turēt

1

Pārdot

Tehniskais rādītājs

By Trading Central

30.475 / 31.345Atbalsts un pretestība

Īstermiņā

Weak Bullish Evidence

Vidējā termiņā

Bearish Evidence

Ilgtermiņā

Bearish Evidence

Noskaņojums

By Acuity

148 / 381 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Baxter International Inc

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.